EA did announce that The Veilguard underperformed, even if expectations were perhaps set a little too high, but blaming this ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Kate Stratten leads Chapel Hill's IntraHealth International as it faces challenges in the wake of the Trump administration’s ...

The Gaithersburg organization, Identity will partner its clients with jobs at local automobile dealerships and provide ...